Purpose of review Neonatal home phototherapy is novel approach to de-institutionalize and demystify newborn healthcare through early and careful identification of newborns who are at risk for severe hyperbilirubinemia but are at low risk for acute bilirubin encephalopathy (kernicterus) such that bilirubin reducing intervention may be administered in a safe, remotely medical-supervised setting such as the family home. Recent findings Advent of affordable light-emitting-diode (LED) lamps configured to a specific narrow blue-green wavelength with the clinical capacity to provide remotely but intensely supervised medical care in a low-risk setting as well as the ability to track bilirubin values with point-of-care settings has allowed several global communities to structure curricula and standard-operating-procedures to practice neonatal home phototherapy. Thus far, the literature review has demonstrated no adverse outcomes for kernicterus, exchange transfusion, any complications attributed to phototherapy or rising bilirubin levels. These practices have been implemented in diverse cultural and geographic communities. More extensive and evidence-based experiences would enhance both clinical and societal roles of this intervention. However, this approach is not an alternative for those needing in-hospital treatment, such as preterm neonates, those with proven hemolytic disorders, sepsis or other neonatal illnesses that require intensive cardio-pulmonary care. Most importantly, active parent-partnership, education, support and collaboration is the primary key to success. Summary Neonatal home phototherapy is feasible; it is safe, and it is a valid alternative to in-hospital phototherapy if candidate neonates are selected carefully to exclude unexpected experiences. Clinicians need to selectively identify the most suitable candidates (babies and their families), provide thorough and understandable parent education, and carefully guide equipment use and maintenance as well as vigilantly track serial TSB levels of infants> Neonates treated at home should have similar care as during in-patient practice. Costs of home phototherapy appear to be considerably less than those for rehospitalization. Advantages of breast-feeding at home are beneficial such that both clinician and family satisfaction is incurred while minimizing any adverse consequences.

Clinical Guidelines and Practical Considerations For Neonatal Home Phototherapy

期刊论文
发表日期：

2026年6月3日

查看全文

Vinod K. Bhutani,
Kishore R Kumar

摘要

Purpose of review

Neonatal home phototherapy is novel approach to de-institutionalize and demystify newborn healthcare through early and careful identification of newborns who are at risk for severe hyperbilirubinemia but are at low risk for acute bilirubin encephalopathy (kernicterus) such that bilirubin reducing intervention may be administered in a safe, remotely medical-supervised setting such as the family home.

Recent findings

Advent of affordable light-emitting-diode (LED) lamps configured to a specific narrow blue-green wavelength with the clinical capacity to provide remotely but intensely supervised medical care in a low-risk setting as well as the ability to track bilirubin values with point-of-care settings has allowed several global communities to structure curricula and standard-operating-procedures to practice neonatal home phototherapy. Thus far, the literature review has demonstrated no adverse outcomes for kernicterus, exchange transfusion, any complications attributed to phototherapy or rising bilirubin levels. These practices have been implemented in diverse cultural and geographic communities. More extensive and evidence-based experiences would enhance both clinical and societal roles of this intervention. However, this approach is not an alternative for those needing in-hospital treatment, such as preterm neonates, those with proven hemolytic disorders, sepsis or other neonatal illnesses that require intensive cardio-pulmonary care. Most importantly, active parent-partnership, education, support and collaboration is the primary key to success.

Summary

Neonatal home phototherapy is feasible; it is safe, and it is a valid alternative to in-hospital phototherapy if candidate neonates are selected carefully to exclude unexpected experiences. Clinicians need to selectively identify the most suitable candidates (babies and their families), provide thorough and understandable parent education, and carefully guide equipment use and maintenance as well as vigilantly track serial TSB levels of infants> Neonates treated at home should have similar care as during in-patient practice. Costs of home phototherapy appear to be considerably less than those for rehospitalization. Advantages of breast-feeding at home are beneficial such that both clinician and family satisfaction is incurred while minimizing any adverse consequences.